Cellular immunotherapy

Active cellular therapies usually involve the removal of immune cells from the blood or from a tumor. Those specific for the tumor are cultured and returned to the patient where they attack the tumor. Cell types that can be used in this way are natural killer cells, lymphokine-activated killer cells, cytotoxic T cells and dendritic cells. The only US-approved cell-based therapy is Dendreon's Provenge, for the treatment of prostate cancer.

  • Dendritic cell therapy

Related Conference of Cellular immunotherapy

March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain
June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
July 29-30, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
October 21-22, 2019

12th Annual Congress on Immunology & Immunogenetics

Rome, Italy
November 12-13, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
November 21-22, 2019

World Conference on Vaccine and Immunology

Dubai, UAE

Cellular immunotherapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in